This Biotech with Breakout MS Drug Draws Big Investment
A breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
Learn the telltale signs you should revise your budget, including income changes, expense spikes, and shifting priorities.
24,979 articlesA breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
A clear, actionable look at beyond (xair) 2026 earnings and what a Q4 earnings call could reveal. Learn how to read t...
SpaceX’s rapid move into index funds signals a shift in how private tech breakthroughs reach everyday investors. This...
As quantum tech moves from lab to real-world use, two stocks stand out for 2026. This guide explains why IonQ and IBM...
Parsons Corp faces a tough mix: a record backlog rising margins boost profitability, yet an upcoming policy and contr...
Bloom Energy skyrocketed over 248% in the first half of 2026, delivering eye-popping gains for early investors. This ...
The UK debate over exempting overtime from income tax sounds like a simple win for workers, but the plan hides seriou...
July markets showed a cautious tone as Ondas revealed a fresh $70 million order backlog. The stock jumped, while majo...
Procter & Gamble has built a remarkable dividend-growth legacy, raising payouts for seven decades. This article break...
What if the Oracle of Omaha retired having not purchased his beloved stock after decades of bets? This article dives ...
When the market opened on Wednesday, Jabil shares surged as investors digested stronger-than-expected Q3 results and ...
Even as alkami stock down 50% frames a challenging chapter, a new large stake in Alkami Technology points to a differ...